The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of afatinib plus selumetinib in patients with KRAS mutation-positive colorectal, non-small cell lung and pancreatic cancer.
 
Sanne Huijberts
No Relationships to Disclose
 
Emilie Van Brummelen
No Relationships to Disclose
 
Carla M.L.- Van Herpen
Research Funding - AstraZeneca; Bayer (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Ipsen; Ipsen (Inst); Merck; MSD; MSD (Inst); Novartis; Regeneron (Inst); Sanofi
 
Ingrid M.E. Desar
No Relationships to Disclose
 
Frans Opdam
No Relationships to Disclose
 
Robin Van Geel
No Relationships to Disclose
 
Serena Marchetti
No Relationships to Disclose
 
Neeltje Steeghs
Research Funding - AB Science (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cytovation (Inst); Deciphera (Inst); Genentech (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); InteRNA (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst)
 
Kim Monkhorst
Honoraria - AstraZeneca; MSD
Consulting or Advisory Role - Abbvie; AstraZeneca; BMSi; MSD; Roche
Speakers' Bureau - Benecke; Medtalks
Research Funding - AstraZeneca; Roche
Travel, Accommodations, Expenses - Roche; Takeda
 
Bas Thijssen
No Relationships to Disclose
 
Hilde Rosing
No Relationships to Disclose
 
Alwin Huitema
Research Funding - Merus NV (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Jos H. Beijnen
Employment - Modra Pharmaceuticals
Stock and Other Ownership Interests - Modra Pharmaceuticals
Honoraria - Modra Pharmaceuticals
Research Funding - Astex Pharmaceuticals (Inst); Modra Pharmaceuticals (Inst); Neon Therapeutics (Inst); PharmaMar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent dealing with the pharmaceutical formulation of oral taxanes (Inst)
 
Rene Bernards
No Relationships to Disclose
 
Jan H. M. Schellens
Employment - Modra Pharmaceuticals; Synthon
Stock and Other Ownership Interests - Modra Pharmaceuticals
Honoraria - Debiopharm Group
Consulting or Advisory Role - Debiopharm Group
Patents, Royalties, Other Intellectual Property - Oral taxanes